The business of bioanalysis: summary of panel discussions
Bioanalysis
.
2018 Aug 1;10(15):1169-1175.
doi: 10.4155/bio-2018-0153.
Epub 2018 Jul 23.
Authors
Neil Spooner
1
2
,
Chris Beaver
3
,
John Kolman
4
,
Scott Summerfield
5
,
Liz Thomas
6
,
Tom Verhaeghe
7
,
Amanda Wilson
8
Affiliations
1
Spooner Bioanalytical Solutions Ltd, Hertford, SG13 8BQ, UK.
2
School of Life & Medical Sciences, University of Hertfordshire, Hatfield, AL10 9AB, UK.
3
Ligand Binding & Exploratory Bioanalysis, Syneos Health, 301D College Road East, Princeton, NJ 08540, USA.
4
Translational Medicine, QPS, Delaware Technology Park, 1 Innovation Way, Newark, DE 19711, USA.
5
Bioanalysis, Immunogenicity & Biomarkers, GlaxoSmithKline Pharmaceuticals, Research & Development, Park Road, Ware, SG12 0DP, UK.
6
Alderley Analytical Ltd, BioHub at Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK.
7
Development Bioanalysis, Janssen Research & Development, a Division of Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium.
8
Astra Zeneca, Building 623, Babraham Research Campus, Babraham, Cambridge, CB22 3AT, UK.
PMID:
30033746
DOI:
10.4155/bio-2018-0153
No abstract available
MeSH terms
Chemistry Techniques, Analytical / economics
Chemistry Techniques, Analytical / methods*
Costs and Cost Analysis
Drug Industry
Social Control, Formal